Drugmakers ask FDA to approve another Alzheimer’s drug, similar to Aduhelm
Sep 29, 2021
Drugmakers Eisai and Biogen are putting the Food and Drug Administration to the test with a request to approve a second Alzheimer’s drug that works like aducanumab (Aduhelm), the new, yet controversial,...
Alzheimer’s origin story is about metabolism and lifestyle, scientists contend
Apr 02, 2021
Alzheimer’s Disease is increasingly being referred to as insulin resistance of the brain, or Type 3 diabetes, a research team says.
FDA advisers vote ‘no’ on drug that may slow Alzheimer’s progression
Nov 09, 2020
If approved by the FDA, aducanumab would be the first-ever drug marketed to slow progression of the brain-wasting disease, according to its developer. But an advisory committee was unconvinced of the drug’s...
FDA approves imaging drug for use in Alzheimer’s diagnostics
Jun 10, 2020
Tauvid is the first drug to enable tau protein detection in adults who are being evaluated for Alzheimer’s, the agency reports.
Study ties beta amyloid to sleep dysfunction and impaired cognition
Oct 20, 2019
A mechanism tied to disrupted sleep may underlie the link between beta amyloid deposits and cognitive impairment in seniors with cognitive disorders.
Promising Alzheimer’s drug fails in follow-up tests, researchers announce
May 28, 2013
A “breakthrough” Alzheimer’s drug now looks much less promising after follow-up experiments failed to reproduce successful results, scientists recently announced. Non-standard use of...
Experimental Alzheimer’s drug fails to deliver in closely watched clinical trial
Jul 25, 2012
Alzheimer’s researchers met with disappointment Monday when officials from Pfizer announced that the experimental drug bapineuzumab failed to improve dementia symptoms in a Phase 3 trial.
Protective gene mutation gives hope to Alzheimer’s drug development
Jul 16, 2012
Alzheimer’s researchers got a huge boost last week with the publication of a study showing that a rare genetic mutation prevents the buildup of beta amyloid in the brain.
Study: New test might help diagnose Alzheimer’s earlier
Jun 24, 2011
A new test that measures amyloid levels in the spinal fluid of people with mild cognitive impairment could help physicians more accurately predict who will develop Alzheimer’s, a new study finds.
Alzheimer’s-detecting PET scans could be on the market within a year
Jun 08, 2011
Nuclear medicine experts say positron emission tomography (PET) scans that detect beta amyloid plaques in the brain could make it to the marketplace within the next year. Beta-amyloid is a naturally occurring...